Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?

Citation
Yfc. Vanrenterghem, Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?, CURR OP NEP, 8(6), 1999, pp. 669-674
Citations number
35
Categorie Soggetti
Urology & Nephrology
Journal title
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
ISSN journal
10624821 → ACNP
Volume
8
Issue
6
Year of publication
1999
Pages
669 - 674
Database
ISI
SICI code
1062-4821(199911)8:6<669:WCIIPI>2.0.ZU;2-Q
Abstract
Cyclosporine and tacrolimus are potent inhibitors of the calcineurin-depend ent cytokine synthesis in activated lymphocytes. In renal transplant patien ts tacrolimus is more powerful in preventing severe and refractory rejectio ns, even when compared with the new cyclosporine microemulsion formulation. Both drugs are equally nephrotoxic, but tacrolimus induces less hypertensi on and less pronounced hyperlipidaemia, Especially in some categories of pa tients, a higher incidence of de-novo diabetes mellitus is seen with tacrol imus therapy. Curr Opin Nephrol Hypertens 8:669-674. (C) 1999 Lippincott Wi liiams & Wilkins.